Biochemistry, Genetics and Molecular Biology
Gene
100%
Genetics
96%
Polygenic Score
38%
Single Nucleotide Polymorphism
38%
Genotyping
36%
Genomics
30%
Exome
30%
Genetic Divergence
28%
Single-Nucleotide Polymorphism
26%
Genetic Architecture
19%
Case-Control Study
19%
Heritability
16%
Genome Wide Association Study
16%
Protein
16%
Genetic Determinism
15%
Gene Expression Profiling
13%
Gene Ontology
13%
Haplotype
12%
Spectrum
12%
Neurexin
11%
Waist Circumference
10%
Genetic Correlation
10%
Folliculogenesis
9%
Coiled Coil
9%
Nervous System Development
9%
Epidermolysis bullosa
9%
Genetic Predisposition
9%
Interferon Type I
9%
Pharmacogenomics
9%
Clinical Trial
9%
C9orf72
9%
Mendelian Randomization
8%
Relatedness
8%
Candidate Gene
7%
Light
7%
Expression Quantitative Trait Loci
5%
Quality Control
5%
Membrane
5%
Genotype
5%
Neurotrophin
5%
Medicine and Dentistry
Meta-Analysis
43%
Therapeutic Procedure
40%
Analysis
36%
Genome Wide Association Study
31%
Psoriasis
29%
Genotype
23%
Disease
21%
Patient
19%
Clinical Feature
19%
Symptom
16%
Body Mass Index
16%
Gene
16%
Biological Marker
14%
Single Nucleotide Polymorphism
13%
DNA
13%
Association
11%
Depression
9%
Pharmacogenomics
9%
Anorexia Nervosa
9%
Treatment Response
9%
Psychiatry
9%
Acneiform Eruption
9%
Buccal Swab
9%
Apoplexy
9%
Rheumatoid Arthritis
9%
Pathogenesis
9%
Pustulosis Palmaris Et Plantaris
9%
Hair Follicle
9%
Ovary Follicle Development
9%
Mediator
9%
Gene Expression Profiling
9%
Differential Gene Expression
9%
Depression
9%
Cognitive Behavioral Therapy
9%
Psychosis
9%
Anxiety
9%
UK Biobank
7%
Drug
6%
Dermatosis
5%
Drug Therapy
5%
Spontaneous Remission
5%
Neuroscience
Expression Analysis
31%
Brain
30%
Major Depressive Disorder
29%
Anxiety Disorder
29%
Genotype
24%
Antidepressant
19%
Anxiety
13%
Behavior (Neuroscience)
11%
Bipolar Disorder
9%
Cell Line
9%
Cognitive Function
9%
Cytochrome P450 2C19
9%
Genetic Mapping
9%
Body Mass Index
9%
Clozapine
9%
Fk 506 Binding Protein
9%
Attention Deficit Hyperactivity Disorder
9%
Frontal Lobe
6%
Escitalopram
5%
Citalopram
5%
Pervasive Developmental Disorder
5%
Adult Attention Deficit Hyperactivity Disorder
5%
5-HTTLPR
5%